The 3-phase evolution of stored red blood cells and the clinical trials: an obvious relationship
- PMID: 28263178
- PMCID: PMC5336342
- DOI: 10.2450/2017.0317-16
The 3-phase evolution of stored red blood cells and the clinical trials: an obvious relationship
Conflict of interest statement
The Authors declare no conflicts of interest.
References
-
- Heddle NM, Cook RJ, Arnold DM, et al. Effect of short-term vs. long-term blood storage on mortality after transfusion. New Engl J Med. 2016;375:1937–45. - PubMed
-
- Glynn SA, Klein HG, Ness PM. The red blood cell storage lesion: the end of the beginning. Transfusion. 2016;56:1462–8. - PubMed
-
- Prudent M, Tissot JD, Lion N. In vitro assays and clinical trials in red blood cell aging: lost in translation. Transfus Apher Sci. 2015;52:270–6. - PubMed
-
- Paglia G, D’Alessandro A, Rolfsson O, et al. Biomarkers defining the metabolic age of red blood cells during cold storage. Blood. 2016;128:E43–50. - PubMed
-
- Goel R, Johnson DJ, Scott AV, et al. Red blood cells stored 35 days or more are associated with adverse outcomes in high-risk patients. Transfusion. 2016;56:1690–8. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources